Want to join the conversation?
Jim Suva of Citi asks about DMS as it seemed like operating at a loss. $JBL said that in its DMS, specifically Green Point, the company has put investments in and there are two main variables for 3Q16. One was a hit in volumes that was abrupt and couldn't get out of some of the variable cost. Secondly, most of cost allocation for Green Point.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.